77 related articles for article (PubMed ID: 19499709)
21. Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug-transport mechanism.
Zhang M; Wang G; Shapiro A; Zhang JT
Biochemistry; 1996 Jul; 35(30):9728-36. PubMed ID: 8703944
[TBL] [Abstract][Full Text] [Related]
22. Detection of P-glycoprotein-mediated multidrug resistance against anthelmintics in Haemonchus contortus using anti-human mdr1 monoclonal antibodies.
Kerboeuf D; Guégnard F; Vern YL
Parasitol Res; 2003 Sep; 91(1):79-85. PubMed ID: 12898231
[TBL] [Abstract][Full Text] [Related]
23. Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells.
Michieli M; Damiani D; Michelutti A; Grimaz S; Geromin A; Fanin R; Russo D; Masolini P; Baccarani M
Leuk Lymphoma; 1996 Sep; 23(1-2):99-105. PubMed ID: 9021691
[TBL] [Abstract][Full Text] [Related]
24. Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Nagy H; Goda K; Fenyvesi F; Bacsó Z; Szilasi M; Kappelmayer J; Lustyik G; Cianfriglia M; Szabó G
Biochem Biophys Res Commun; 2004 Mar; 315(4):942-9. PubMed ID: 14985103
[TBL] [Abstract][Full Text] [Related]
25. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
[TBL] [Abstract][Full Text] [Related]
26. MRP1 and P-glycoprotein expression assays would be useful in the additional detection of treatment non-responders in CML patients without ABL1 mutation.
Park SH; Park CJ; Kim DY; Lee BR; Kim YJ; Cho YU; Jang S
Leuk Res; 2015 Oct; 39(10):1109-16. PubMed ID: 26248945
[TBL] [Abstract][Full Text] [Related]
27. Overcoming multi-drug resistance using an intracellular anti-MDR1 sFv.
Heike Y; Kasono K; Kunisaki C; Hama S; Saijo N; Tsuruo T; Kuntz DA; Rose DR; Curiel DT
Int J Cancer; 2001 Apr; 92(1):115-22. PubMed ID: 11279614
[TBL] [Abstract][Full Text] [Related]
28. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
Frey T; Yue S; Haugland RP
Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
[TBL] [Abstract][Full Text] [Related]
29. Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samples.
van der Pol MA; Broxterman HJ; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2003 Sep; 55(1):14-21. PubMed ID: 12949955
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Van Acker KL; Van Hove LM; Boogaerts MA
Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
[TBL] [Abstract][Full Text] [Related]
31. [Functional activity and expression of P-glycoprotein in chronic myeloid leukemia].
Stromskaia TP; Rybalkina EIu; Turkina AG; Zabotina TN; Logacheva NP; Zakharova ES; Mechetner EB; Baryshnikov AIu; Khoroshko ND; Stavrovskaia AA
Ter Arkh; 2001; 73(7):20-5. PubMed ID: 11523404
[TBL] [Abstract][Full Text] [Related]
32. [Multidrug resistance (MDR) in oncology].
Souvirón Rodríguez A; Ruiz Gómez MJ; Morales Moreno JA; Martínez Morillo M
An Med Interna; 1997 Mar; 14(3):145-53. PubMed ID: 9235086
[TBL] [Abstract][Full Text] [Related]
33. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.
Müller MR; Lennartz K; Nowrousian MR; Dux R; Tsuruo T; Rajewsky MF; Seeber S
Cytometry; 1994 Jan; 15(1):64-72. PubMed ID: 7512893
[TBL] [Abstract][Full Text] [Related]
34. Characterization and epitope mapping of several new anti-P-glycoprotein monoclonal antibodies.
Shapiro AB; Duthie M; Childs S; Okubo T; Ling V
Int J Cancer; 1996 Jul; 67(2):256-63. PubMed ID: 8760596
[TBL] [Abstract][Full Text] [Related]
35. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G
Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216
[TBL] [Abstract][Full Text] [Related]
36. [The correlation of multidrug resistance phenotype with clinical response to chemotherapy in laryngeal cancer].
Li X; Yang C; Su Z; Song Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Sep; 15(9):401-2, 404. PubMed ID: 12541888
[TBL] [Abstract][Full Text] [Related]
37. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
38. H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein.
Wei N; Sun H; Wang F; Liu G
Cancer Chemother Pharmacol; 2011 May; 67(5):1017-25. PubMed ID: 20640574
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
40. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
